Sanofi (SNY) NASDAQ
44.91
+0.31(+0.70%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
44.91
+0.31(+0.70%)
Currency In USD
| Market Cap | 100.67B |
| Enterprise Value | 114.8B |
| P/E Ratio | 8.93 |
| PEG Ratio | -0.66 |
| Price/Sales Ratio | 1.61 |
| Price/Book Ratio | 1.33 |
| Enterprise/Revenue | 1.85 |
| Enterprise/EBITDA | 9.72 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.18 |
| Operating Margin | 0.25 |
| Return On Assets | 0.08 |
| Return On Equity | 0.15 |
| Revenue | 46.72B |
| Revenue/Share | 47.73 |
| Gross Profit | 33.79B |
| EBITDA | 12.68B |
| Net Income | 7.81B |
| Diluted EPS | 2.03 |
| Total Cash | 7.66B |
| Total Cash/Share | 6.27 |
| Total Debt | 20.33B |
| Total Debt/Equity | 0.31 |
| Current Ratio | 1.09 |
| Book Value Per Share | 58.76 |
| 52-Week Change | -19.7 |
| 52-Week High | 56.93 |
| 52-Week Low | 43.32 |
| Moving Average 50 Days | 46.55 |
| Moving Average 200 Days | 48.31 |
| Average Volume | 4.14M |
| Shares Outstanding | 2.44B |
| % Held by Institutions | 9.13 |
| Trailing Annual Dividend Rate | 3.92 |
| Trailing Annual Dividend Yield | 5.04 |
| Payout Ratio | 0.45 |
| Last Split Factor | 5:1 |
| Last Split Date | September 30, 2013 |